Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of mesalazine on fecal calprotectin in ulcerative colitis
IRCT20250426065472N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Salcrozine in autoimmune colitis, sponsored by Isfahan University of Medical Sciences. Primary endpoint: Change in fecal calprotectin. Started Oct 2025; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on IRCT20250426065472N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250426065472N1.